Chinese Sle Treatment And Research Group

This study compares two new drugs, vunakizumab and ivarmacitinib, against standard steroid treatment for adults with active Takayasu's arteritis, a rare inflammatory disease of the blood vessels. Researchers will enroll 180 participants across multiple centers to see which treatm…

This small, early-stage study is testing a new biologic drug called Firsekibart for people with mild to moderate lupus. It's for patients whose symptoms, like fever, joint pain, or rashes, haven't improved enough with standard medications. The goal is to see if blocking a specifi…